A previous study showed that decreased proportions of tumor-infiltrating CD4+ T cells and a reversed CD4+/CD8+ cell ratio were significantly associated with the clinical outcome of patients with cervical cancer [32]. This evidence concerns the gene CD4 and cervical cancer.